Development of novel agents based on nitric oxide for the control of colon cancer

被引:0
|
作者
Vassiliki KOZONI
Theophilos ROSENBERG
Basil RIGAS
机构
[1] Division of Cancer Prevention,Stony Brook University Stony Brook,NY 11794-5200,USA
[2] First Department of Surgery Laikon Hospital,Athens University,11527 Athens,Greece
关键词
nitric oxide-donating NSAIDs; nitric oxide aspirin; colon cancer; chemoprevention nitric oxide;
D O I
暂无
中图分类号
R735.3 [肠肿瘤];
学科分类号
100214 ;
摘要
Nitric oxide-donating nonsteroidal anti-inflammatory drugs (NO-NSAIDs) repre-sent a novel class of compounds that hold promise as agents for the control ofcolon cancer.They are derivatives of conventional NSAIDs that have been modi-fied by adding to them,via a spacer molecule,a nitric oxide releasing moiety.Theexpectation is that the combined effects of NO and the NSAID moiety will exceedthose of each structural component alone.Extensive work has demonstrated theirpotency and efficacy in preclinical models of colon cancer.The mechanism ofaction of NO-NSAIDs involves the modulation of several critical cellular signalingpathways,whereas the induction of a state of oxidative stress,at least by NO-aspirin,appears to be a major proximal event.Clinical trials are needed to assessthe role of NO-NSAIDs in the control of colon cancer.
引用
收藏
页码:1429 / 1433
页数:5
相关论文
共 50 条
  • [21] Gingerol aspirinate derivatives as novel chemopreventive agents for colon cancer
    Zhu, Yingdong
    Wang, Fang
    Zhao, Yantao
    Wang, Pei
    Sang, Shengmin
    CANCER RESEARCH, 2016, 76
  • [22] Nitric oxide donors: Novel cancer therapeutics (Review)
    Huerta, Sergio
    Chilka, Sapna
    Bonavida, Benjamin
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2008, 33 (05) : 909 - 927
  • [23] Development of arylated nitric oxide-releasing prodrugs as anticancer agents
    Wilde, TC
    Saavedra, JE
    Shami, PJ
    Findlay, VF
    Townsend, DM
    Tew, KD
    Ji, XH
    Keefer, LK
    NITRIC OXIDE-BIOLOGY AND CHEMISTRY, 2006, 14 (04): : A16 - A16
  • [24] Nitric oxide-based drug development
    Keefer, Larry
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2010, 240
  • [25] Nitric oxide augments the cytotoxicity of chemotherapeutic agents used in colorectal cancer
    Fleming, M
    Sales, K
    Winslet, A
    BRITISH JOURNAL OF SURGERY, 2005, 92 (10) : 1303 - 1303
  • [26] Stimulation and repression of cancer development by caveolae and nitric oxide
    Blouin, Cedric M.
    Ojcius, David M.
    BIOMEDICAL JOURNAL, 2015, 38 (05) : 365 - +
  • [27] NOSH-aspirin: A novel nitric oxide- and hydrogen sulfide-releasing hybrid for treatment of colon cancer
    Lee, Diana H.
    Nesbitt, Diandra E.
    Chattopadhyay, Mitali
    Kodela, Ravinder
    Kashfi, Khosrow
    CANCER RESEARCH, 2012, 72
  • [28] Nitric oxide and P-glycoprotein modulate the phagocytosis of colon cancer cells
    Kopecka, Joanna
    Campia, Ivana
    Brusa, Davide
    Doublier, Sophie
    Matera, Lina
    Ghigo, Dario
    Bosia, Amalia
    Riganti, Chiara
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2011, 15 (07) : 1492 - 1504
  • [29] Therapeutic Potential of Nitric Oxide-Modified Drugs in Colon Cancer Cells
    Mojic, Marija
    Mijatovic, Sanja
    Maksimovic-Ivanic, Danijela
    Miljkovic, Djordje
    Stosic-Grujicic, Stanislava
    Stankovic, Marija
    Mangano, Katia
    Travali, Salvatore
    Donia, Marco
    Fagone, Paolo
    Zocca, Mai-Britt
    Al-Abed, Yousef
    McCubrey, James A.
    Nicoletti, Ferdinando
    MOLECULAR PHARMACOLOGY, 2012, 82 (04) : 700 - 710
  • [30] COLON CANCER STEM CELL PROLIFERATION AND CHEMORESISTANCE ARE PROMOTED BY ENDOGENOUS NITRIC OXIDE
    Puglisi, M. A.
    Tesori, V.
    Cenciarelli, C.
    Cappellari, M.
    Martini, M.
    Di Francesco, A. M.
    Giorda, E.
    Carsetti, R.
    Gasbarrini, G.
    Ricci-Vitiani, L.
    Gasbarrini, A.
    DIGESTIVE AND LIVER DISEASE, 2015, 47 : E144 - E144